Latest News Archive
Please select Category, Year, and then Month to display items
03 January 2023
|
Story Lacea Loader
|
Photo Evert Kleynhans
Dr Dolf van Niekerk.
The University of the Free State (UFS) would like to express its condolences to the family and friends of South African author, Dr Dolf van Niekerk, on his passing.
Dr Van Niekerk, the recipient of an
honorary doctorate from the UFS, passed away on 31 December 2022. The UFS awarded a Doctor of Letters to Dr Dolf van Niekerk during its April 2021 graduation ceremony.
Dr Van Niekerk was a celebrated author who also achieved fame as a dramatist and radio presenter. An alumnus of the UFS, he received a BA degree from the university cum laude in 1949. He also played a role in academia and was an emeritus professor at the University of Pretoria until his retirement in 1994. His work includes 27 books in philosophy, poetry, fiction, drama, and memoirs, for which he has received numerous awards. These include the
Eugene Marais Prize, the MER Prize, and the Scheepers Award for Youth Literature.
“Dr van Niekerk is a Kovsie alumnus with a deep connection to the Free State. He played a significant role in the country’s literary history, and it was an honour for the university to award him with an honorary degree. A wordsmith of note, Dr van Niekerk’s contributions to South African literature, radio, and stage will live on," says
Prof Francis Petersen, Rector and Vice-Chancellor.
New research informs improved treatment of brain inflammation
2017-10-13
Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish
Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.
Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.
Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.
Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology